Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Theory of Literature
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Alzheimer's Disease Diagnosis and Treatments
Tell A Friend
Tell someone you know about this product.
Alzheimer's Disease Diagnosis and Treatments
Retail Price: $245.00
10% Online Discount
You Pay:

Editors: Marisa R. Boyd
Book Description:
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's Disease (AD), which involves the parts of the brain that control thought, memory, and language. Age is the most important known risk factor for AD. The course the disease takes and the speed at which changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. This book presents research in the study of Alzheimer's Disease, including diagnosis, testing and treatment of this condition. (Imprint: Nova Biomedical Press)

We’ve partnered with Copyright Clearance Center to make it easy for you to request permissions to reuse Nova content.
For more information, click here or click the "Get Permission" button below to link directly to this book on Copyright Clearance Center's website.

Table of Contents:

Alzheimer’s Disease – 100 Years of Research: A Historical Perspective and Commentary;pp. 1-5
(Walter J. Lukiw, Neuroscience and opthalmology, Louisiana State University, New Orleans,USA)

Controlled and Automatic Memory Processing in Alzheimer’s Disease;pp. 7-24
(John M. Hudson, Dept. of Psychology, University of Lincoln, UK)

Age of Onset Related Differences in Clinical and Neuropsychological Features of Alzheimer’s Disease;pp. 25-33
(Erin Saito, Eliot Licht, Aaron M. McMurtray and Mario F. Mendez, John A Burns School of Medicine, University of Hawaii, and others)

Early Onset Dementia with Abundant Non-Neuritic Aβ Plaques and without Significant Neuronal Loss: Report of Two Japanese Autopsy Cases;pp. 35-58
(Osamu Yokota, Kuniaki Tsuchiya and Shigetoshi Kuroda, Dept. of Neuropathology, Tokyo Institute of Psychiatry, Japan, and others)

How and Where Does Aβ Exert its Toxic Effects in Alzheimer’s Disease?;pp. 59-70
(Damian C. Crowther, Richard M. Page, Leila Luheshi and David A. Lomas, Dept. of Medicine, University of Cambridge, UK)

The Spatial Patterns of β-Amyloid (Aβ) Deposits and Neurofibrillary Tangles (NFT) in Late-Onset Sporadic Alzheimer's Disease;pp. 71-82
(Richard A. Armstrong)

Brain Function in Altered States of Consciousness: Comparison between Alzheimer Dementia and Vegetative State;pp. 83-98
(Mélanie Boly, Eric Salmon and Steven Laureys, Neurology Dept. and Cyclotron Research Centre,University of Liege, Belgium)

Cognitive Deficits in Mild Cognitive Impairment;pp. 99-109
(F. Ribeiro, M. Guerreiro and A. de Mendonça,Institute Of Molecular Medicine,University of Lisbon, Portugal)

Mitochondrial Pathology and Alzheimer’s Disease;pp. 111-124
(Michelangelo Mancuso, Cecilia Carlesi, Selina Piazza and Gabriele Siciliano, Dept. of Neuroscience, University of Pisa, Italy)

Calmodulin Binds to and Regulates the Activity of Beta-Secretase (BACE1);pp. 125-135
(Sara E. Chavez and Danton H. O’Day, Dept. of Biology, University of Toronto, Mississauga)

Transgenic Models of Alzheimer’s Pathology: Success and Caveats;pp. 137-168
(Benoît Delatour, Camille Le Cudennec, Nadine El Tannir-El Tayara and Marc Dhenain, NAMC Laboratory, Centre Universitaire Bat, Orsay, France and others)

Relevance of COX-2 Inhibitors in Alzheimer’s Disease;pp. 169-182
(Amita Quadros, Laila Abdullah, Nikunj Patel and Claude-Henry Volm, Roskamp Institute, Sarasota, Fl., USA)

Copper Studies in Alzheimer’s Disease;pp. 183-201
(R. Squitti, G. Dal Forno, S. Cesaretti, M. Ventriglia, P. M. Rossini, Dept. of Neuroscience, AFaR - Ospedale Fatebenefratelli, Rome Italy)

Theoretical Comparison of Copper Chelators as Anti-Alzheimer and Anti-Prion Agents;pp. 203-208
(Liang Shen, Hong-Yu Zhang and Hong-Fang Ji, Shandong Provincial Center for Bioinformatic Engineering and Technique,Shandong University of Technology, Zibo, China)

Toward a More Rational Approach to the Treatment of Patients with Dementia with Psychosis and Behavioral Disturbance;pp. 209-211
(Suzanne Holroyd, Dept. of Psychiatry and Neurobehavioral Science, University of Virginia, Charlottesville, USA)

Amyloid Clearing Immunotherapy ;pp. 213-220
(Shawn J. Kile and John M. Olichney, Dept. of Neurology, University of California, Davis, USA)

Use of Antidepressants in Older People with Mental Illness; A Systematic Study of Tolerability and Use in Different Diagnostic Groups;pp. 221-229
(Stephen Curran, Debbie Turner, Shabir Musa, Andrew Byrne and John Wattis, School of Human and Health Services, University of Huddersfield, Wakefield, UK)

Cystatin C Role in Alzheimer Disease: from Neurodegeneration to Neuroregeneration;pp. 231-241
(Luisa Benussi, Giuliano Binetti and Roberta Ghidoni, NeuroBioGen Lab and Memory Clinic,Centro San Giovanni di DioFatebenefratelli, Brescia, Italy)

A Theoretical Evaluation on Acetylcholinesterase-Inhibitory Potential of Quercetin;pp. 243-249
(Hong-Fang Ji and Hong-Yu Zhang, Shandong Provincial Research Center for Bioinformatic Engineering and Technique, Shandong University of Technology, Zibo, China)

Therapy with Drug Product AZD-103 May Ease Alzheimer's Disease;pp. 251-253
(Antonio Orlacchio and Toshitaka Kawarai, Laboratory of Neurogenetics, CERC-IRCCS, Santa Lucia, Italy and others)

NSAIDs in Animal Models of Alzheimer's Disease;pp. 255-280
(M. G. Giovannini, C. Scali, A. Bellucci, G. Pepeu and F. Casamenti, Dept. of Pharmacology, University of Florence, Italy)

Index pp.281-298

      Neurology - Laboratory and Clinical Research Developments
      Aging Issues, Health and Financial Alternatives
   Binding: Hardcover
   Pub. Date: 2011 1st quarter
   Pages: 298.pp
   ISBN: 978-1-61122-064-3
   Status: AV
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Alzheimer's Disease Diagnosis and Treatments